Kimberly-Clark Q1 sales rise on organic growth and pricing resilience

Grafa
Kimberly-Clark Q1 sales rise on organic growth and pricing resilience
Kimberly-Clark Q1 sales rise on organic growth and pricing resilience
Heidi Cuthbert
Written by Heidi Cuthbert
Share

Kimberly-Clark (NASDAQ:KMB) announced its first-quarter 2026 financial results on Tuesday, April 28, 2026, showcasing the resilience of its global brands in a competitive consumer environment.

The Texas-based personal care leader posted net sales of $4.2 billion, a 2.7% increase year-over-year, driven by a 2.5% rise in organic sales.

The quarter was characterized by solid execution across its core segments, including Personal Care, Consumer Tissue, and K-C Professional.

Adjusted operating profit climbed 3.7% to $732 million, reflecting the company’s ongoing focus on productivity improvements and revenue growth management strategies to offset persistent input cost pressures.

Profitability metrics presented a nuanced picture for the quarter.

Adjusted earnings per share (EPS) attributable to Kimberly-Clark was $1.97, up 2.1% from the prior-year period.

However, adjusted EPS from continuing operations saw a slight dip of 1.2% to $1.60.

Despite this, the firm’s cash generation remained robust, with cash provided by operations totaling $745 million for the quarter.

Kimberly-Clark’s balance sheet as of March 31, 2026, showed total debt of $7.1 billion.

The company has maintained an active investment cycle, with year-to-date capital spending reaching $424 million as it continues to modernize its manufacturing footprint and digital capabilities.

Frequently asked questions

Connect with us

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.